Skip to main content

Table 5 Clinicopathologic features of 44 patients with resected IPMNs (WF patients)

From: The efficacy of pancreatic juice cytology with liquid-based cytology for evaluating malignancy in patients with intraductal papillary mucinous neoplasm

 

All patients (n = 44)

Smear method (n = 29)

LBC (n = 15)

P value

Age (IQR), years

69 (63–74)

68 (61–72)

74 (68–76)

0.135

Sex (male/female)

32/12

22/7

10/5

0.516

Location of main lesion (Ph/Pbt)

29/15

19/10

10/5

0.939

Type of IPMN, n (%)

0.341

  BD

24 (55)

17 (59)

7 (47)

 

  Mixed

18 (41)

10 (34)

8 (53)

 

  MD

2 (5)

2 (7)

0 (0)

 

Pathological diagnosis, n (%)

0.105

  L-IGD

31 (70)

18 (62)

13 (87)

 

  HGD

5 (11)

5 (17)

0 (0)

 

  IC

8 (18)

6 (21)

2 (13)

 

Diameter of dilated branch duct (IQR), mm

28.0 (19.3–35.0)

30.0 (19.5–42.0)

23.0 (19.0–29.0)

0.725

 ≥ 30 mm, n (%)

20 (45)

17 (59)

3 (20)

0.015

Diameter of MPD (IQR), mm

5.0 (4.0–7.0)

5.0 (4.0–7.0)

5.0 (4.0–8.0)

0.542

 5–9 mm, n (%)

22 (50)

14 (48)

8 (53)

0.751

Patients with MN, n (%)

24 (55)

17 (59)

7 (47)

0.450

 Height of MN (IQR), mm

3.9 (3.0–4.8)

4.0 (3.0–6.0)

3.0 (1.0–4.0)

0.044

SPACE, n (%)

6 (14)

1 (3)

5 (33)

0.006

  1. IPMN, intraductal papillary mucinous neoplasm; WF, worrisome features; LBC, liquid-based cytology; IQR, interquartile range; Ph, pancreatic head; Pbt, pancreatic body and tail; BD, branch duct; MD, main duct; L-IGD, low-to intermediate-grade dysplasia; HGD, high-grade dysplasia; IC, invasive cancer; MPD, main pancreatic duct; MN, mural nodule; SPACE, serial pancreatic juice. Aspiration cytological examination